Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × UNKNOWN × nabiximols × Clear all

Phase

Phase 1 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

OTHER 4 UNKNOWN 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1

Interventions

S 1 (combination) 12 Capecitabine 11 Paclitaxel 9 Cisplatin 9 apatinib 8 Oxaliplatin 8 pyrotinib 6 nimotuzumab 6 130-nm albumin-bound paclitaxel 6 titanium silicide 5 sintilimab 5 camrelizumab 5 anlotinib 5 Etoposide 5 Docetaxel 5 Carboplatin 5 Trastuzumab 4 Radiotherapy, Intensity-Modulated 4 Irinotecan 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 nedaplatin 3 Vinorelbine 3 Temozolomide 3 Tegafur 3 Taxes 3 Radiosurgery 3 Gemcitabine 3 Fluorouracil 3 Epirubicin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00530764 2013-06-20

SPRAY

GWPharm

Phase 2 Completed

360 enrolled 18 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡